XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1Close
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Assets    
Cash and cash equivalents $ 8,439 $ 7,822
Investments 1,108 925
Accounts receivable, net 20,563 17,722
Inventories 4,630 5,645
Other current assets 2,263 2,169
Assets of businesses held for sale 6,354 3,068
Total current assets 43,357 37,351
Long-term investments 16,025 17,985
Reinsurance recoverables 4,672 4,835
Property and equipment 3,607 3,695
Goodwill 44,258 44,259
Other intangible assets 30,491 30,863
Other assets 3,293 3,421
Separate account assets 7,416 7,430
Assets of businesses held for sale, non-current 0 2,922
TOTAL ASSETS 153,119 152,761 Close
Liabilities    
Current insurance and contractholder liabilities 5,788 5,514
Pharmacy and other service costs payable 24,284 19,815
Accounts payable 8,118 8,553
Accrued expenses and other liabilities 8,857 9,955
Short-term debt 1,715 2,775
Liabilities of businesses held for sale 3,215 2,104
Total current liabilities 51,977 48,716
Non-current insurance and contractholder liabilities 10,641 10,904
Deferred tax liabilities, net 7,029 7,173
Other non-current liabilities 3,653 3,441
Long-term debt 31,053 28,155
Separate account liabilities 7,416 7,430
Liabilities of businesses held for sale, non-current 0 591
TOTAL LIABILITIES 111,769 106,410 Close
Contingencies — Note 16
Redeemable noncontrolling interests 0 107
Shareholders' equity    
Common stock [1] 4 4
Additional paid-in capital 30,292 30,669
Accumulated other comprehensive loss (2,324) (1,864)
Retained earnings 40,978 41,652
Less: Treasury stock, at cost (27,769) (24,238)
TOTAL SHAREHOLDERS' EQUITY 41,181 46,223
Other noncontrolling interests 169 21
Total equity 41,350 46,244 Close
Total liabilities and equity $ 153,119 $ 152,761
[1] Par value per share, $0.01; shares issued, 402 million as of March 31, 2024 and 400 million as of December 31, 2023; authorized shares, 600 million.